A pilot study of Glycopyrrolate premedication for endoscopic submucosal dissectio

Not Applicable

Completed

• Conditions: Diseases of the digestive system

• Registration Number: KCT0001540
• Lead Sponsor: Gachon University Gil Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 March 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 192

Inclusion Criteria

Patients receiving the submucosal dissection for the treatment of gastric adenoma or early gastric cancer under conscious sedation

Exclusion Criteria

1) who have hypersensitivity to this drug
2) The argument of this drug contraindications
(Glaucoma, obstructive urinary diseases, gastrointestinal obstructive disorders, paralytic ileus,
unstable cardiovascular status in acute hemorrhage,
severe ulcerative colitis,myasthenia, megacolon of complication of ulcerative colitis)
3) Acute • Chronic hepatitis, acute • chronic renal failure, coronary artery disease, congestive heart failure, arrhythmia, asthma, chronic obstructive pulmonary disease and other disorders in patients with severe systemic
4) not suitable to determine the other researchers determined the patient

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
the presence of hypoxemia due to oropharyngeal secretion;the overall satisfaction of operator;The degree of bronchial secretions;the presence of aspiration;the presence of cough due to oropharyngeal secretion

Secondary Outcome Measures

Name	Time	Method
Presence or absence of complications (aspiration pneumonia, perforation, hemorrhage, hypertension, hypotension, palpitations, urinary disorders, etc.)